Paulo Campregher, MD, PhD (Member)

Hospital Israelita Albert Einstein

Dr. Campregher is a hematologist and molecular pathologist with a focus on molecular diagnosis. He works at the clinical laboratory of Hospital Albert Einstein since 2011 developing and supervising NGS assays for diagnostic purposes in oncology and hematology. He is also an associate professor at Albert Einstein Graduate Program in Health Sciences with a research focus in myeloid malignancies. He is also the coordinator of short duration courses in Precision Medicine applied to oncology and pediatric oncology.

Dr. Campregher has worked as research associate at Fred Hutchinson Cancer Research Center, Seattle, WA, in 2009, where he was part of the team that developed the technology for high throughput sequencing of immune receptors (TCR). That work was the basis for the launching of the company Adaptive Biotech (Seattle, WA). He also served as director of medical affairs for Foundation Medicine in Brazil from 2013 to 2015.

Education

• Medical School – Universidade Estadual de Campinas, Brazil
• Residency and Fellowship - Universidade Estadual de Campinas, Brazil
• PhD - Universidade Estadual de Campinas, Brazil
• Postdoctoral Research Fellow, Immunology Program, Fred Hutchinson Cancer Research Center, Seattle, WA

Professional membership

• Cancer Genomics Consortium
• Brazilian Society of Laboratorial Medicine
• Precision Medicine Comitee – Brazilian Society of Pediatric Oncology